IP Library Granted Patent US 11,894,138
Granted Patent B2
US 11,894,138 · App. 18/171,149 · Granted Feb 6, 2024

Remote diagnostic testing and treatment

Inventors: Michael W. Ferro, Jr. (Palm Beach, FL); Sam Miller (Hollywood, FL); Colman Thomas Bryant (Fort Lauderdale, FL); Zachary Carl Nienstedt (Wilton Manors, FL); Marco Magistri (Miami, FL); Adam Charles Carlson (Miami, FL); Igor Javier Rodriguez (Miami, FL); James Thomas Heising (Richland, WA); John Ray Permenter (Miami, FL)
Assignee: EMED LABS, LLC
G16H40/67G06T19/006G16H10/60G16H20/10G16H50/20G06K19/06028G06K19/06037
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,894,138
App. No.
18/171,149
Granted
Feb 6, 2024
Kind
B2
Abstract

A medical diagnostic kit are described. In one example, a medical diagnostic kit includes a container, and a plurality of medical diagnostic test kits located within the container. Each of the plurality of medical diagnostic test kits can include equipment necessary to perform a particular self-administered medical diagnostic test. The plurality of medical diagnostic test kits can include at least a first medical diagnostic kit adapted to facilitate user completion of a first medical diagnostic test and a second medical diagnostic kit adapted to facilitate user completion of a second medical diagnostic test different from the first medical diagnostic test. The container can include a machine-readable code located on an external surface of the container.

Claims (43)

1. A drug testing system comprising:

a drug test kit adapted to facilitate user completion of a drug test comprising:

a test reference element; and

a test kit container bearing a machine-readable code on an external surface thereof, the machine-readable code configured to be imaged by a camera of a user computing device to enable:

providing a fiducial point from which a coordinate frame for an augmented reality presentation can be established using the camera and a display of the user computing device;

causing the user computing device to display a user-selectable graphic on the display of the user computing device that, when selected by a user, causes a software application stored on the user computing device to access a webpage that enables initiation of the augmented reality presentation that includes display of augmented reality content relating to the drug test kit;

causing a computing system to establish an electronic video conference session between a proctor device and the user computing device, wherein:

during the electronic video conference session, a proctor views, on the proctor device, a live video of the user taking the drug test,

the live video is captured using the camera of the user computing device of the user, and

the drug test results in a drug indicator indicating a result of the drug test that is viewable by the proctor in the live video;

causing the computing system to receive an indication that the drug indicator indicates that the user has tested positive for the drug based on the drug test, wherein the indication is provided by the proctor using the proctor device and based on the proctor viewing the live video; and

causing the computing system to verify that testing procedures associated with the drug test are completed properly by analyzing monitored video frame data associated with the live video received from the user computing device to determine at least one of:

that a swab used by the user during the drug test was inserted into an orifice at a proper insertion depth,

that a testing solution used during the drug test was correctly applied by the user to a test card associated with the drug test,

that the test card remains undisturbed during a predetermined dwell time associated with the drug test, and

that a horizontal or vertical distance between a patient reference element and the test reference element remains under a predetermined threshold value;

wherein the computing system comprises an electronic storage medium storing computer-executable instructions and one or more processors configured to execute the computer-executable instructions.

2. The system of claim 1 , wherein the machine-readable code is further configured to enable causing the computing system to transmit the indication to a third party.

3. The system of claim 1 , wherein the machine-readable code is further configured to enable causing the computing system to display information regarding the indication to the user on the user computing device.

4. The system of claim 1 , wherein the machine-readable code is further configured to enable causing the computing system to display information regarding the indication to the proctor on the proctor device.

5. The system of claim 1 , wherein the augmented reality content provides instructions for performing at least one step of the drug test.

6. The system of claim 1 , wherein the drug test is provided in the drug test kit, wherein the drug test kit further comprises a plurality of drug tests, and wherein each of the plurality of drug tests is for testing for a different drug.

7. The system of claim 1 , wherein the drug test is provided in a medical diagnostic test kit that comprises a plurality of medical diagnostic test kits.

8. A method for proctored examination for a drug test_provided within a drug test kit comprising a test reference element and a test kit container bearing a machine-readable code on an external surface thereof, the method comprising, in response to the machine-readable code being imaged by a camera of a user computing device:

providing a fiducial point from which a coordinate frame for an augmented reality presentation can be established using the camera and a display of the user computing device;

causing the user computing device to display a user-selectable graphic on the display of the user computing device that, when selected by a user, causes a software application stored on the user computing device to access a webpage that enables initiation of the augmented reality presentation that includes display of augmented reality content relating to the drug test kit;

causing a computing system to receive a user request from the user computing device of the user for the proctored examination for a drug;

causing the computing system to establish an electronic video conference session between a proctor device and the user computing device, wherein:

during the electronic video conference session, a proctor views, on the proctor device, a live video of the user taking the drug test,

the live video is captured using a camera of the user computing device of the user, and

the drug test results in a drug indicator indicating a result of the drug test that is viewable by the proctor in the live video;

causing the computing system to receive an indication that the drug indicator indicates that the user has tested positive for the drug based on the drug test, wherein the indication is provided by the proctor using the proctor device and based on the proctor viewing the live video; and

causing the computing system to verify that testing procedures associated with the drug test are completed properly by analyzing monitored video frame data associated with the live video received from the user computing device to determine at least one of:

that a swab used by the user during the drug test was inserted into an orifice at a proper insertion depth,

that a testing solution used during the drug test was correctly applied by the user to a test card associated with the drug test,

that the test card remains undisturbed during a predetermined dwell time associated with the drug test, and

that a horizontal or vertical distance between a patient reference element and the test reference element remains under a predetermined threshold value.

9. The method of claim 8 , wherein the method further comprises causing the computing system to transmit the indication to a third party.

10. The method of claim 8 , wherein the method further comprises causing the user computing device to display information regarding the indication to the user on the user computing device.

11. The method of claim 8 , wherein the method further comprises causing the proctor device to display information regarding the indication to the proctor on the proctor device.

12. The method of claim 8 , wherein the augmented reality content provides instructions for performing at least one step of the drug test.

13. The method of claim 8 , wherein the drug test is provided in the drug test kit, wherein the drug test kit further comprises a plurality of drug tests, and wherein each of the plurality of drug tests is for testing for a different drug.

14. The method of claim 8 , wherein the drug test is provided in a medical diagnostic test kit that comprises a plurality of medical diagnostic test kits.

Assignments (4)
CHANGE OF NAME Recorded Aug 13, 2025
From: EMED POPULATION HEALTH, LLC
To: EMED POPULATION HEALTH, INC.
Reel/Frame 072435/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2025
From: EMED LABS, LLC
To: EMED POPULATION HEALTH, LLC
Reel/Frame 071208/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2023
From: PERMENTER, JOHN RAY
To: EMED LABS, LLC
Reel/Frame 065936/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2023
From: FERRO, MICHAEL W., JR.; MILLER, SAM; BRYANT, COLMAN THOMAS; NIENSTEDT, ZACHARY CARL; MAGISTRI, MARCO; CARLSON, ADAM CHARLES; RODRIGUEZ, IGOR JAVIER; HEISING, JAMES THOMAS
To: EMED LABS, LLC
Reel/Frame 062755/0057 →
Continuity (8)
Continuation 17700141 · Mar 21, 2022
Provisional Application 63266233 · Dec 30, 2021
Provisional Application 63266158 · Dec 29, 2021
Provisional Application 63202723 · Jun 22, 2021
Provisional Application 63202028 · May 24, 2021
Provisional Application 63179101 · Apr 23, 2021
Provisional Application 63164669 · Mar 23, 2021
Related Publication 20230207118A1 · Jun 29, 2023
Cited By (2)
US 12,515,057 US 12,705,737